NeuroBionics

Another successful study in the books! Last week the team traveled to Philly to meet with our collaborators at the University of Pennsylvania.?It was a great opportunity to test our product and gather some amazing user feedback. Thanks again to the UPenn team for an incredible day!

Gang’s all here ?? ! We kicked off 2025 with a fantastic strategy and goal-setting retreat, which was both productive and a great way to bring our growing team together. With this powerhouse team and ambitious goals for the year ahead, we're excited to make big things happen. Stay tuned!

Another week, another exciting addition to the NeuroBionics Team! We're thrilled to welcome Jason Fortier to NeuroBionics as our Head of Product Development! Jason is a leader in the medical device industry with over 20 years of experience transforming innovative concepts into commercial products. His product development expertise spans catheters, absorbable hydrogels, and combination devices, with additional experience in preclinical research and clinical strategy. Previously, Jason held leadership roles at Covidien, Medtronic, Ablative Solutions, Augmenix and Confluent Surgical, driving innovation across multiple sectors of medtech. ?? Welcome to the team, Jason!???

NeuroBionics is pleased to introduce our newest team member Ross Tsukashima! Ross joins us with over two decades of experience driving innovation and commercialization of transformative medical technologies across neurovascular, structural heart, endoscopy, and minimally-invasive solutions. Previously, Ross held leadership roles at Integra LifeSciences and Rebound Therapeutics, where he spearheaded the development of advanced neurosurgical and endovascular devices, amassing a portfolio of over 50 issued patents. ?? Welcome aboard, Ross! ??

Last week, we were featured in TechCrunch and shared the news that we closed an oversubscribed $5M seed round of funding ?? Now, we're happy to share the official press release! https://lnkd.in/dAq53Q3W

NeuroBionics is excited to announce the closing of our oversubscribed $5M Seed Round! ?? We’re thrilled to have an amazing roster of investors joining us on this journey. This round was led by Dolby Family Ventures and supported by Future Ventures, GreyMatter, Focalpoint Partners, Lionheart Ventures, Jumpspace Ventures, and Dr. Thomas Insel MD, former Director of the National Institute of Mental Health. At NeuroBionics, we are passionate about expanding access to neuromodulation therapies for millions of patients with neurological disorders. This funding is a testament to the groundbreaking work our team is doing and will enable us to accelerate our mission to transform the standard of care for these patients. To all our supporters and believers—thank you! Together, we are moving closer to a future where no patient is left behind. If you’re as passionate about advancing neuromodulation as we are, let’s connect! #NeuroBionics #Neuromodulation #Neurotech #Innovation #Healthcare

I'll be at #JPM25 next week! If you'd like to meet up and learn more about what we're building at NeuroBionics, please reach out!

?? NeuroBionics is heading to the?43rd J.P. Morgan Healthcare Conference?in San Francisco, January 13–16, 2025! Our Co-founder & CEO,?MJ Antonini, will be on-site and looks forward to connecting with?#medtech innovators, investors, and entrepreneurs. If you’re curious about how NeuroBionics is revolutionizing access to neuromodulation therapy, let’s chat! Reach out to MJ via direct message or email to schedule a meeting. ?? Be on the lookout over the next few days for a big announcement—we can’t wait to share it with you! We’re excited to share our vision for the future of #bioelectronics medicine and explore opportunities for collaboration! #JPM2025 #neurotech #neuromodulation #medtech #NeuroBionics

Excited to start the year by announcing the latest addition to our team, Jonathan Zhang! JZ brings over 15 years of experience from the medical device industry in materials and chemistries for non-fouling surfaces on medical devices, with particular expertise in blood-contacting devices. Welcome aboard JZ! ?

Excited to start the year by announcing the latest addition to our team, Jonathan Zhang! JZ brings over 15 years of experience from the medical device industry in materials and chemistries for non-fouling surfaces on medical devices, with particular expertise in blood-contacting devices. Welcome aboard JZ! ?